Idiopathic inflammatory demyelinating disorders after acute transverse myelitis

K H Chan1, K L Tsang, G C Y Fong

  • 1Division of Neurology, University Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.

Insights

Recurrent acute transverse myelitis (ATM) can indicate connective tissue diseases or idiopathic inflammatory demyelinating disorders like neuromyelitis optica (NMO). Early NMO recognition is vital for distinct treatment and preventing deficits.

Area of Science:

  • Neurology
  • Immunology
  • Demyelinating Diseases

Background:

  • Acute transverse myelitis (ATM) is often post-infectious.
  • Recurrent ATM is associated with connective tissue diseases (CTD) and idiopathic inflammatory demyelinating disorders (IIDD), including multiple sclerosis (MS) and neuromyelitis optica (NMO).
  • Previous research may have misclassified NMO and idiopathic recurrent transverse myelitis (IRTM) as MS.

Purpose of the Study:

  • To investigate the long-term outcomes of patients experiencing their first idiopathic ATM attack.
  • To differentiate between single ATM, recurrent ATM linked to CTD, and recurrent neuroinflammation indicative of IIDD.
  • To assess the diagnostic and prognostic significance of MRI findings and clinical presentation in IIDD.

Main Methods:

  • Retrospective study of idiopathic ATM patients over six years.
  • Exclusion of known causes of myelopathy.
  • Follow-up assessments including neurological examination and spinal MRI.

Main Results:

  • Of 32 patients, 63% had a single ATM attack.
  • 9 patients (28.1%) developed recurrent neuroinflammation consistent with IIDD (3 NMO, 2 NMO variants, 3 IRTM, 1 MS).
  • NMO and its variants showed significantly greater spinal MRI abnormalities and poorer neurological prognosis compared to non-recurrent ATM.

Conclusions:

  • Idiopathic ATM can be the initial presentation of serious IIDD, particularly NMO and its variants.
  • Distinguishing NMO from MS is crucial due to differing treatment strategies.
  • Early identification of NMO and its variants is essential for timely intervention and improved patient outcomes.

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...